EPZM Annual SG&A
$133.96 M
+$8.78 M+7.01%
31 December 2021
Summary:
As of February 5, 2025, EPZM annual selling, general & administrative expenses is $133.96 million, with the most recent change of +$8.78 million (+7.01%) on December 31, 2021. During the last 3 years, it has risen by +$89.98 million (+204.64%).EPZM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Quarterly SG&A
$24.11 M
-$3.09 M-11.37%
30 June 2022
Summary:
As of February 5, 2025, EPZM quarterly selling, general & administrative expenses is $24.11 million, with the most recent change of -$3.09 million (-11.37%) on June 30, 2022. Over the past year, it has dropped by -$9.78 million (-28.86%).EPZM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM TTM SG&A
-$5.06 B
-$207.73 M-4.29%
30 June 2022
Summary:
As of February 5, 2025, EPZM TTM selling, general & administrative expenses is -$5.06 billion, with the most recent change of -$207.73 million (-4.29%) on June 30, 2022. Over the past year, it has dropped by -$5.19 billion (-3820.14%).EPZM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.0% | -28.9% | -3820.1% |
3 y3 years | +204.6% | +53.6% | -7501.5% |
5 y5 years | +260.3% | +115.8% | -7501.5% |
EPZM Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | at high | -33.8% | -3760.4% |
Epizyme Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2022 | - | $24.11 M(-11.4%) | $114.97 M(-7.8%) |
Mar 2022 | - | $27.20 M(-11.8%) | $124.75 M(-6.9%) |
Dec 2021 | $133.96 M(+7.0%) | $30.86 M(-5.9%) | $133.96 M(-3.0%) |
Sept 2021 | - | $32.79 M(-3.2%) | $138.11 M(+1.6%) |
June 2021 | - | $33.89 M(-6.9%) | $135.89 M(+0.9%) |
Mar 2021 | - | $36.41 M(+4.0%) | $134.66 M(+7.6%) |
Dec 2020 | $125.18 M(+83.3%) | $35.02 M(+14.5%) | $125.18 M(+10.1%) |
Sept 2020 | - | $30.57 M(-6.4%) | $113.69 M(+13.5%) |
June 2020 | - | $32.66 M(+21.3%) | $100.20 M(+20.4%) |
Mar 2020 | - | $26.93 M(+14.4%) | $83.24 M(+21.9%) |
Dec 2019 | $68.30 M(+55.3%) | $23.53 M(+37.7%) | $68.30 M(+19.9%) |
Sept 2019 | - | $17.09 M(+8.9%) | $56.94 M(+10.8%) |
June 2019 | - | $15.70 M(+31.0%) | $51.38 M(+10.3%) |
Mar 2019 | - | $11.99 M(-1.5%) | $46.60 M(+6.0%) |
Dec 2018 | $43.97 M(+18.3%) | $12.17 M(+5.6%) | $43.97 M(+9.3%) |
Sept 2018 | - | $11.53 M(+5.6%) | $40.23 M(+5.8%) |
June 2018 | - | $10.91 M(+16.6%) | $38.02 M(-0.7%) |
Mar 2018 | - | $9.36 M(+11.0%) | $38.27 M(+2.9%) |
Dec 2017 | $37.18 M | $8.43 M(-9.5%) | $37.18 M(+2.3%) |
Sept 2017 | - | $9.31 M(-16.6%) | $36.33 M(+5.2%) |
June 2017 | - | $11.17 M(+35.1%) | $34.54 M(+12.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2017 | - | $8.27 M(+9.1%) | $30.80 M(+8.5%) |
Dec 2016 | $28.37 M(+18.7%) | $7.58 M(+0.8%) | $28.37 M(+5.8%) |
Sept 2016 | - | $7.52 M(+1.3%) | $26.81 M(+3.3%) |
June 2016 | - | $7.42 M(+27.0%) | $25.96 M(+5.9%) |
Mar 2016 | - | $5.85 M(-2.8%) | $24.51 M(+2.5%) |
Dec 2015 | $23.90 M(+14.5%) | $6.02 M(-9.9%) | $23.90 M(+4.7%) |
Sept 2015 | - | $6.68 M(+11.8%) | $22.82 M(+4.6%) |
June 2015 | - | $5.97 M(+14.0%) | $21.81 M(+3.1%) |
Mar 2015 | - | $5.24 M(+6.1%) | $21.15 M(+1.3%) |
Dec 2014 | $20.87 M(+48.6%) | $4.93 M(-12.9%) | $20.87 M(+2.7%) |
Sept 2014 | - | $5.67 M(+6.8%) | $20.31 M(+11.4%) |
June 2014 | - | $5.31 M(+7.1%) | $18.23 M(+13.9%) |
Mar 2014 | - | $4.96 M(+13.2%) | $16.00 M(+13.9%) |
Dec 2013 | $14.04 M(+87.0%) | $4.38 M(+22.1%) | $14.04 M(+17.0%) |
Sept 2013 | - | $3.59 M(+16.5%) | $12.00 M(+19.5%) |
June 2013 | - | $3.08 M(+2.7%) | $10.04 M(+16.8%) |
Mar 2013 | - | $3.00 M(+28.5%) | $8.60 M(+14.5%) |
Dec 2012 | $7.51 M(+50.2%) | $2.33 M(+43.1%) | $7.51 M(+45.1%) |
Sept 2012 | - | $1.63 M(-0.5%) | $5.17 M(+46.0%) |
June 2012 | - | $1.64 M(-14.1%) | $3.54 M(+85.9%) |
Mar 2012 | - | $1.91 M | $1.91 M |
Dec 2011 | $5.00 M | - | - |
FAQ
- What is Epizyme annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Epizyme?
- What is Epizyme annual SG&A year-on-year change?
- What is Epizyme quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Epizyme?
- What is Epizyme quarterly SG&A year-on-year change?
- What is Epizyme TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Epizyme?
- What is Epizyme TTM SG&A year-on-year change?
What is Epizyme annual selling, general & administrative expenses?
The current annual SG&A of EPZM is $133.96 M
What is the all time high annual SG&A for Epizyme?
Epizyme all-time high annual selling, general & administrative expenses is $133.96 M
What is Epizyme annual SG&A year-on-year change?
Over the past year, EPZM annual selling, general & administrative expenses has changed by +$8.78 M (+7.01%)
What is Epizyme quarterly selling, general & administrative expenses?
The current quarterly SG&A of EPZM is $24.11 M
What is the all time high quarterly SG&A for Epizyme?
Epizyme all-time high quarterly selling, general & administrative expenses is $36.41 M
What is Epizyme quarterly SG&A year-on-year change?
Over the past year, EPZM quarterly selling, general & administrative expenses has changed by -$9.78 M (-28.86%)
What is Epizyme TTM selling, general & administrative expenses?
The current TTM SG&A of EPZM is -$5.06 B
What is the all time high TTM SG&A for Epizyme?
Epizyme all-time high TTM selling, general & administrative expenses is $138.11 M
What is Epizyme TTM SG&A year-on-year change?
Over the past year, EPZM TTM selling, general & administrative expenses has changed by -$5.19 B (-3820.14%)